Literature DB >> 24961491

Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate.

Grégory Thiabaud1, Jonathan F Arambula, Zahid H Siddik, Jonathan L Sessler.   

Abstract

In an effort to increase the stability and control the platinum reactivity of platinum-texaphyrin conjugates, two Pt(IV) conjugates were designed, synthesized, and studied for their ability to form DNA adducts. They were also tested for their anti-proliferative effects using wild-type and platinum-resistant human ovarian cancer cell lines (A2780 and 2780CP, respectively). In comparison to an analogous first-generation Pt(II) chimera, one of the new conjugates provided increased stability in aqueous environments. Using a combination of (1) H NMR spectroscopy and FAAS (flameless atomic-absorption spectrometry), it was found that the Pt(IV) center within this conjugate undergoes photoinduced reduction to Pt(II) upon exposure to glass-filtered daylight, resulting in an entity that binds DNA in a controlled manner. Under conditions in which the Pt(IV) complex is reduced to the corresponding Pt(II) species, these new conjugates demonstrated potent anti-proliferative activity in both test ovarian cancer cell lines.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  conjugates; drug design; photo-activation; platinum; texaphyrin

Mesh:

Substances:

Year:  2014        PMID: 24961491      PMCID: PMC4241752          DOI: 10.1002/chem.201403094

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  28 in total

1.  Reaction monitoring of platinum(II) complex--5'-guanosine monophosphate adduct formation by ion exchange liquid chromatography/electrospray ionization mass spectrometry.

Authors:  P Zöllner; A Zenker; M Galanski; B K Keppler; W Lindner
Journal:  J Mass Spectrom       Date:  2001-07       Impact factor: 1.982

2.  Use of platinum as a modifier in the sensitive detection of tellurium in biological samples.

Authors:  Z H Siddik; R A Newman
Journal:  Anal Biochem       Date:  1988-07       Impact factor: 3.365

3.  In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.

Authors:  R A Miller; K Woodburn; Q Fan; M F Renschler; J L Sessler; J A Koutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-11-01       Impact factor: 7.038

4.  NMR investigation of the spontaneous thermal- and/or photoinduced reduction of trans dihydroxido Pt(IV) derivatives.

Authors:  Emanuele Petruzzella; Nicola Margiotta; Mauro Ravera; Giovanni Natile
Journal:  Inorg Chem       Date:  2013-02-18       Impact factor: 5.165

5.  New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs.

Authors:  Alina Nemirovski; Inbal Vinograd; Khuloud Takrouri; Ana Mijovilovich; Annette Rompel; Dan Gibson
Journal:  Chem Commun (Camb)       Date:  2010-02-12       Impact factor: 6.222

Review 6.  Molecular mechanisms of resistance and toxicity associated with platinating agents.

Authors:  Cara A Rabik; M Eileen Dolan
Journal:  Cancer Treat Rev       Date:  2006-11-03       Impact factor: 12.111

7.  Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.

Authors:  Shanta Dhar; Weston L Daniel; David A Giljohann; Chad A Mirkin; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

8.  Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions.

Authors:  Ezequiel Wexselblatt; Eylon Yavin; Dan Gibson
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-17       Impact factor: 15.336

9.  Motexafin gadolinium reacts with ascorbate to produce reactive oxygen species.

Authors:  Darren Magda; Nikolay Gerasimchuk; Philip Lecane; Richard A Miller; John E Biaglow; Jonathan L Sessler
Journal:  Chem Commun (Camb)       Date:  2002-11-21       Impact factor: 6.222

Review 10.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

View more
  10 in total

1.  Porphyrinoid Drug Conjugates.

Authors:  Jonathan F Arambula; Jonathan L Sessler
Journal:  Chem       Date:  2020-07-09       Impact factor: 22.804

2.  Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents.

Authors:  Grégory Thiabaud; Guangan He; Sajal Sen; Kathryn A Shelton; Wallace B Baze; Luke Segura; Julie Alaniz; Ruben Munoz Macias; Greg Lyness; Alan B Watts; Hyun Min Kim; Hyunseung Lee; Mi Young Cho; Kwan Soo Hong; Rick Finch; Zahid H Siddik; Jonathan F Arambula; Jonathan L Sessler
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

3.  Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.

Authors:  Gregory Thiabaud; Rebecca McCall; Guangan He; Jonathan F Arambula; Zahid H Siddik; Jonathan L Sessler
Journal:  Angew Chem Int Ed Engl       Date:  2016-07-05       Impact factor: 15.336

4.  Comparison of different sample preparation methods for platinum determination in cultured cells by graphite furnace atomic absorption spectrometry.

Authors:  Man Xiao; Zaiju Huang; Jing Cai; Jinghui Jia; Yuzeng Zhang; Weihong Dong; Zehua Wang
Journal:  PeerJ       Date:  2017-01-18       Impact factor: 2.984

5.  Gd(iii)-Pt(iv) theranostic contrast agents for tandem MR imaging and chemotherapy.

Authors:  Casey J Adams; Thomas J Meade
Journal:  Chem Sci       Date:  2020-01-28       Impact factor: 9.825

6.  An intramolecular photoswitch can significantly promote photoactivation of Pt(iv) prodrugs.

Authors:  Zhiqin Deng; Cai Li; Shu Chen; Qiyuan Zhou; Zoufeng Xu; Zhigang Wang; Houzong Yao; Hajime Hirao; Guangyu Zhu
Journal:  Chem Sci       Date:  2021-04-01       Impact factor: 9.825

7.  A pH responsive complexation-based drug delivery system for oxaliplatin.

Authors:  Bin Li; Zhao Meng; Qianqian Li; Xiayang Huang; Ziyao Kang; Huajin Dong; Junyi Chen; Ji Sun; Yansheng Dong; Jian Li; Xueshun Jia; Jonathan L Sessler; Qingbin Meng; Chunju Li
Journal:  Chem Sci       Date:  2017-04-19       Impact factor: 9.825

Review 8.  Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action.

Authors:  Ziwen Dai; Zhigang Wang
Journal:  Molecules       Date:  2020-11-06       Impact factor: 4.411

Review 9.  Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments.

Authors:  Brondwyn S McGhie; Janice R Aldrich-Wright
Journal:  Biomedicines       Date:  2022-03-01

10.  Towards Imaging Pt Chemoresistance Using Gd(III)-Pt(II) Theranostic MR Contrast Agents.

Authors:  Casey J Adams; Thomas J Meade
Journal:  ChemMedChem       Date:  2021-08-06       Impact factor: 3.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.